Not exactly. Even though both of those focus on GLP-one receptors, Tirz also activates GIP receptors, making it a dual agonist. This broader system is believed to boost its effects on insulin sensitivity and appetite signaling in study styles. Be aware: Anecdotal feed-back from investigation members plus some observational studies https://peptisell.com/product/tirzepatide